Prevalence of Primary Drug Resistance Among Newly Diagnosed HIV-1-Infected Individuals in Hunan Province, China
Author:
Affiliation:
1. Graduate Collaborative Training Base of The First Hospital of Changsha, Hengyang Medical School, University of South China, Hengyang, China.
2. The Institute of HIV/AIDS, The First Hospital of Changsha, Hunan, China.
Publisher
Mary Ann Liebert Inc
Subject
Infectious Diseases,Virology,Immunology
Link
https://www.liebertpub.com/doi/pdf/10.1089/aid.2022.0077
Reference25 articles.
1. Early Antiretroviral Therapy in South African Children Reduces HIV-1-Infected Cells and Cell-Associated HIV-1 RNA in Blood Mononuclear Cells
2. Incidence and types of HIV-1 drug resistance mutation among patients failing first-line antiretroviral therapy
3. Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China
4. Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sustained Spread of HIV-1 CRF55_01B in its Place of Origin: Dynamics and Hotspots;The Journal of Infectious Diseases;2024-08-29
2. Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022;Journal of Antimicrobial Chemotherapy;2024-07-24
3. Retrospective Study on Genetic Diversity and Drug Resistance among People Living with HIV at an AIDS Clinic in Beijing;Pharmaceuticals;2024-01-16
4. Pretreatment HIV Drug Resistance and the Molecular Transmission Network among HIV-positive 1 Individuals in China in 2022: a Multicenter Observational Study (Preprint);2023-07-17
5. Treatment persistence of bictegravir/emtricitabine/tenofovir alafenamide and efavirenz + lamivudine + tenofovir disoproxil among HIV-1 patients newly starting treatment in Hunan Province in China;BMC Infectious Diseases;2023-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3